579000 Sigma-AldrichTamoxifen Citrate - CAS 54965-24-1 - Calbiochem
Recommended Products
Přehled
Replacement Information |
---|
Tabulka spec. kláve
CAS # | Empirical Formula |
---|---|
54965-24-1 | C₂₆H₂₉NO · C₆H₈O₇ |
Products
Katalogové číslo | Balení | ks/bal. | |
---|---|---|---|
579000-100MG | Skleněná láhev | 100 mg |
Product Information | |
---|---|
CAS number | 54965-24-1 |
ATP Competitive | N |
Form | White to off-white powder |
Hill Formula | C₂₆H₂₉NO · C₆H₈O₇ |
Chemical formula | C₂₆H₂₉NO · C₆H₈O₇ |
Reversible | Y |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | PKC |
Primary Target IC<sub>50</sub> | 10 µM against protein kinase C |
Purity | ≥99% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | Y |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS | |
---|---|
RTECS | KH2387000 |
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Katalogové číslo | GTIN |
579000-100MG | 04055977265934 |
Documentation
Tamoxifen Citrate - CAS 54965-24-1 - Calbiochem MSDS
Title |
---|
Tamoxifen Citrate - CAS 54965-24-1 - Calbiochem Certificates of Analysis
Title | Lot Number |
---|---|
579000 |
References
Přehled odkazů |
---|
Rohlff, C., et al. 1998. Prostate 37, 51. Couldwell, W.J., et al. 1994. FEBS Lett. 345, 43. Baltuch, G.H., et al. 1993. Neurosurgery 33, 495. Powis, G. 1991. Trends Pharmacol. Sci. 12, 188. Issandou, M., et al. 1990. Cancer Res. 50, 5845. O’Brian, C.A., et al. 1985. Cancer Res. 45, 2462. |
Brochure
Title |
---|
Caspases and other Apoptosis Related Tools Brochure |